Zevra Therapeutics, Inc.
A pharmaceutical company focused on developing and commercializing rare disease treatments. The company is developing an orally administered potential treatment for Niemann-Pick disease type C, as well as treatments for idiopathic hypersomnia, narcolepsy, and Ehlers-Danlos syndrome (vEDS), and markets OLPRUVA for the treatment of certain urea cycle disorders (UCDs). Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | Florida |
Employees | 65 |
Founded | 2006 |
Financials | |
|---|---|
Market Capitalization | 244.84M |
Revenue | 28.01M |
Operating Income | -57.17M |
Operating Margin | -204.11% |
Net Income | -50.90M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4532 / 5373 |
Sector : Healthcare | 750 / 1144 |
Industry : Biotechnology | 343 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3494 / 5565 |
Sector : Healthcare | 556 / 1182 |
Industry : Biotechnology | 278 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4355 / 5436 |
Sector : Healthcare | 713 / 1164 |
Industry : Biotechnology | 343 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4287 / 5330 |
Sector : Healthcare | 737 / 1174 |
Industry : Biotechnology | 322 / 667 |